German Biotech’s Gene Therapy for Osteoarthritis Plucked by US Pharma – Labiotech.eu (blog)
Labiotech.eu (blog) |
German Biotech's Gene Therapy for Osteoarthritis Plucked by US Pharma
Labiotech.eu (blog) GeneQuine's gene therapy for osteoarthritis in the knee has been acquired by US pharma company Flexion Therapeutics for up to $64M. GeneQuine is developing a gene therapy for the treatment of osteoarthritis. It uses helper-dependent adenoviruses, which … |
